Less common side effects may include fatigue, headaches, dizziness, or injection site reactions
A number of studies has found that semaglutide and liraglutide could reduce the levels of blood lipids and blood pressure (BP), hence contributing to the reduction of atherosclerosis and CVDs (117119)
There was no head-to-head trial directly comparing these antidiabetic drug classes
Undiagnosed diabetes, he said, is the most likely scenario that would allow for someone to go from not being qualified to being qualified. Since Finley had sleep apnea and testing showing that the drug helped, she learned it could still be covered with a prior authorization thats when you have to get approval from your health insurance before it will cover a medical cost
Evidence from a multicenter, long-term cardiovascular outcome trial demonstrated that GLP-1RAs reduce mortality associated with cardiovascular disease and confer protective effects by decreasing the incidence of myocardial infarction and nonfatal stroke.104 GLP-1RAs have been shown to enhance endothelial cell function through anti-inflammatory and vasodilatory mechanisms